Literature DB >> 15539413

CARD15 gene polymorphisms in patients with spondyloarthropathies identify a specific phenotype previously related to Crohn's disease.

D Laukens1, H Peeters, D Marichal, B Vander Cruyssen, H Mielants, D Elewaut, P Demetter, C Cuvelier, M Van Den Berghe, P Rottiers, E M Veys, E Remaut, L Steidler, F De Keyser, M De Vos.   

Abstract

BACKGROUND: The association between spondyloarthropathy and Crohn's disease is well known. A risk for evolution to Crohn's disease has already been shown in the subgroup of patients with spondyloarthropathy associated with chronic gut inflammation.
OBJECTIVE: To investigate whether the reported polymorphisms in the CARD15 gene, a susceptibility gene for Crohn's disease, are associated with the presence of preclinical intestinal inflammation observed in spondyloarthropathies.
METHODS: 104 patients with spondyloarthropathies were studied. All underwent ileocolonoscopy with biopsies between 1983 and 2004. The prevalence of three single nucleotide polymorphisms in the CARD15 gene (R702W, G908R, and 1007fs) was assessed using restriction fragment length polymorphism-polymerase chain reaction (RFLP-PCR); the patients were compared with an ethnically matched Crohn's disease population and a control population.
RESULTS: The carrier frequency of R702W, G908R, or 1007fs variants in the spondyloarthropathy populations (20%) was similar to the control population (17%), but increased to 38% in the spondyloarthropathy subgroup with chronic gut inflammation. This frequency was significantly higher than in the other spondyloarthropathy subgroups (p = 0.001) or the control group (p = 0.006), but not different from the Crohn's disease group (49%) (NS). This indicates that CARD15 polymorphisms are associated with a higher risk for development of chronic gut inflammation.
CONCLUSIONS: CARD15 gene polymorphisms clearly identify a subgroup of patients with spondyloarthropathies associated with chronic intestinal inflammation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15539413      PMCID: PMC1755516          DOI: 10.1136/ard.2004.028837

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  54 in total

Review 1.  The cutting edge of spondylarthropathy research in the millennium.

Authors:  Kaisa Granfors; Elisabeth Märker-Hermann; Filip de Keyser; Muhammad A Khan; Eric M Veys; David T Y Yu
Journal:  Arthritis Rheum       Date:  2002-03

2.  The molecular classification of the clinical manifestations of Crohn's disease.

Authors:  Tariq Ahmad; Alessandro Armuzzi; Mike Bunce; Kim Mulcahy-Hawes; Sara E Marshall; Timothy R Orchard; Jonathan Crawshaw; Oliver Large; Arjuna de Silva; Julia T Cook; Martin Barnardo; Sue Cullen; Ken I Welsh; Derek P Jewell
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

Review 3.  HLA-B27 and genetic predisposing factors in spondyloarthropathies.

Authors:  J D Reveille; E J Ball; M A Khan
Journal:  Curr Opin Rheumatol       Date:  2001-07       Impact factor: 5.006

4.  Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy.

Authors:  Filip Van Den Bosch; Elli Kruithof; Dominique Baeten; Annemie Herssens; Filip de Keyser; Herman Mielants; Eric M Veys
Journal:  Arthritis Rheum       Date:  2002-03

5.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

6.  CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease.

Authors:  Suzanne Lesage; Habib Zouali; Jean-Pierre Cézard; Jean-Frédéric Colombel; Jacques Belaiche; Sven Almer; Curt Tysk; Colm O'Morain; Miquel Gassull; Vibeke Binder; Yigael Finkel; Robert Modigliani; Corinne Gower-Rousseau; Jeanne Macry; Françoise Merlin; Mathias Chamaillard; Anne-Sophie Jannot; Gilles Thomas; Jean-Pierre Hugot
Journal:  Am J Hum Genet       Date:  2002-03-01       Impact factor: 11.025

7.  Lack of common NOD2 variants in Japanese patients with Crohn's disease.

Authors:  Nagamu Inoue; Kazuo Tamura; Yoshitaka Kinouchi; Yoshihiro Fukuda; Seiichi Takahashi; Yasunori Ogura; Naohiro Inohara; Gabriel Núñez; Yusuke Kishi; Yuji Koike; Tooru Shimosegawa; Takashi Shimoyama; Toshifumi Hibi
Journal:  Gastroenterology       Date:  2002-07       Impact factor: 22.682

8.  CARD15/NOD2 analyses in spondylarthropathy.

Authors:  Corinne Miceli-Richard; Habib Zouali; Suzanne Lesage; Gilles Thomas; Jean-Pierre Hugot; Roula Said-Nahal; Maxime Breban
Journal:  Arthritis Rheum       Date:  2002-05

Review 9.  Update on spondyloarthropathies.

Authors:  Muhammad Asim Khan
Journal:  Ann Intern Med       Date:  2002-06-18       Impact factor: 25.391

10.  The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease.

Authors:  Andrew P Cuthbert; Sheila A Fisher; Muddassar M Mirza; Kathy King; Jochen Hampe; Peter J P Croucher; Silvia Mascheretti; Jeremy Sanderson; Alastair Forbes; John Mansfield; Stefan Schreiber; Cathryn M Lewis; Christopher G Mathew
Journal:  Gastroenterology       Date:  2002-04       Impact factor: 22.682

View more
  30 in total

Review 1.  The transition of acute to chronic bowel inflammation in spondyloarthritis.

Authors:  Liesbet Van Praet; Peggy Jacques; Filip Van den Bosch; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2012-04-17       Impact factor: 20.543

Review 2.  A possible link between Crohn's disease and ankylosing spondylitis via Klebsiella infections.

Authors:  Alan Ebringer; Taha Rashid; Harmale Tiwana; Clyde Wilson
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 2.980

Review 3.  Spondyloarthritis and the microbiome: new insights from an ancient hypothesis.

Authors:  Julia Manasson; Jose U Scher
Journal:  Curr Rheumatol Rep       Date:  2015-02       Impact factor: 4.592

4.  Spondyloarthritis: Gut inflammation in SpA: flagellin joins the dance?

Authors:  Peggy Jacques; Dirk Elewaut
Journal:  Nat Rev Rheumatol       Date:  2013-12-10       Impact factor: 20.543

5.  NOD2/CARD15 gene mutations in patients with gouty arthritis.

Authors:  Ahmet Karaarslan; Senol Kobak; Afig Berdeli
Journal:  Bosn J Basic Med Sci       Date:  2016-11-10       Impact factor: 3.363

Review 6.  Clinical observations programme in SpA: disease parameters, treatment options and practical management issues.

Authors:  Dirk Elewaut; Filip Van den Bosch; Gust Verbruggen; Filip de Keyser; Bert Vander Cruyssen; Herman Mielants
Journal:  Rheumatol Int       Date:  2008-09-26       Impact factor: 2.631

7.  Large-vessel granulomatous vasculitis in Crohn's disease: a clinical pathology conference held by the division of rheumatology at hospital for special surgery.

Authors:  Sabeen Anwar; Gregory R Saboeiro; Amy Yang; Syed F Hoda; Xiaojing Ma; Anne R Bass; Doruk Erkan
Journal:  HSS J       Date:  2010-07-30

Review 8.  The role of the gut and microbes in the pathogenesis of spondyloarthritis.

Authors:  Mark Asquith; Dirk Elewaut; Phoebe Lin; James T Rosenbaum
Journal:  Best Pract Res Clin Rheumatol       Date:  2014-11-15       Impact factor: 4.098

9.  [Update: enterogenic spondylarthritis].

Authors:  Elisabeth Märker-Hermann
Journal:  Z Rheumatol       Date:  2021-05-27       Impact factor: 1.372

10.  Linking Crohn's disease and ankylosing spondylitis: it's all about genes!

Authors:  Dirk Elewaut
Journal:  PLoS Genet       Date:  2010-12-02       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.